0 items

in your cart
$0.00

  • Search for Medications
  • Viewcart | Checkout
  • Manage Account
  •  
  • Click-to-Call  

Prescription Drug Search

Strengths available for Tagrisso:

Tagrisso 40mg
Tagrisso 80mg

Search for a drug:

 

Browse Alphabetically:

A · B · C · D · E · F · G · H · I · J · K · L · M · N
O · P · Q · R · S · T · U · V · W · X · Y · Z · #

Information about GlobalPharmacyMeds.to

SSL Secured Website Certified Global Pharmacy Network Hacker Proof: Safe Shopping Experience 5th Anniversary 2002-2007

List of countries where we can ship Tagrisso:

  • Anguilla
  • Antigua and Barbuda
  • Austria
  • Azerbaijan
  • Barbados
  • Belize
  • Bolivia
  • China
  • Egypt
  • Estonia
  • European Union
  • Finland
  • France
  • Greenland
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Ireland
  • Jordan
  • Korea, Republic of
  • Kuwait
  • Lebanon
  • Mauritius
  • Moldova, Republic of
  • Netherlands
  • Netherlands Antilles
  • New Zealand
  • Nicaragua
  • Norway
  • Peru
  • Romania
  • Saudi Arabia
  • Serbia
  • Slovakia
  • Switzerland
  • Trinidad and Tobago
  • United Kingdom, UK
  • United States, US
  • Vietnam
View All Countries

Latest news releases on Tagrisso:

TAGRISSO® (osimertinib) - Treatment for Non-Small Cell ...

Learn about TAGRISSO® (osimertinib), a once-daily prescription treatment for people with metastatic non-small cell lung cancer (NSCLC) with abnormal EGFR genes.

TAGRISSO® (osimertinib) | Official Global Site

Discover the new first-line TAGRISSO efficacy (PFS) data in NSCLC and access information about safety, MOA, dosing, AURA3 and other resources

Tagrisso - pro.medicin.dk – information om medicin

Voksne 80 mg 1 gang dgl. Dosisreduktion til 40 mg 1 gang dgl., behandlingspause eller helt ophør kan være nødvendig ved bivirkninger, fx interstitiel lungesygdom ...

TAGRISSO® (osimertinib) | Treatment for Non-Small Cell ...

Learn more about TAGRISSO® (osimertinib), a newly approved first-line treatment for your patients with metastatic non-small cell lung cancer (NSCLC).

Tagrisso | European Medicines Agency

Before starting treatment, doctors should use a genetic test to confirm that the patient has an EGFR mutation. Tagrisso is available as 40 and 80 mg tablets.

Tagrisso - min.medicin.dk – information om medicin

Tagrisso skal anvendes med forsigtighed ved dårligt fungerende nyrer eller lever.

Tagrisso: Uses, Dosage, Side Effects & Warnings - Drugs.com

Tagrisso (osimertinib) is used to treat EGFR T790M mutation-positive non-small cell lung cancer. Includes Tagrisso side effects, interactions and indications.

Tagrisso - Apoteket.dk

Findes som tabletter. Voksne. Sædvanligvis 80 mg 1 gang i døgnet. Det kan være nødvendigt at nedsætte dosis, holde en pause eller stoppe helt med behandlingen ...

TAGRISSO™ (AZD9291) approved by the US FDA for patients ...

TAGRISSO™ (AZD9291) approved by the US FDA for patients with EGFR T790M mutation-positive metastatic non-small cell lung cancer

TAGRISSO® (osimertinib) as a Second Treatment

TAGRISSO® (osimertinib) is the only FDA approved treatment that targets the EGFR T790M genetic mutation associated with non-small cell lung cancer (NSCLC).

Customer Service
1-866-799-3435 (Use ref# 10786) | Contact Form
Copyright © 2018 GlobalPharmacyMeds.to All rights reserved. Disclaimer | Privacy Policy
Accepted Credit Cards and Payment: VISA, MASTERCARD and eCHECK